GlassScriptPhysician profile
Samir M Turk
NPI 1770657157
$5,573.01
in general payments reported to CMS, 2019-2025
26 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $80.80 · 2021: $432 · 2022: $170 · 2023: $1,468 · 2024: $1,635 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,588 · Travel and Lodging: $1,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,587.85 |
| Travel and Lodging | $1,839.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,333.30 | 2023-2025 | Onyx Frontier, Turbohawk, Cobalt Dr Mri Surescan |
| Janssen Research & Development, LLC | $1,011.12 | 2023 | |
| Boston Scientific Corporation | $798.02 | 2019-2023 | Fighter, Guidezilla |
| Shockwave Medical, INC | $454.23 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $217.42 | 2020-2021 | |
| Medtronic Vascular, INC. | $164.58 | 2019 | |
| Penumbra, INC. | $102.80 | 2019 | |
| Philips North America LLC | $77.90 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Edwards Lifesciences Corporation | $75.91 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $64.06 | 2021 | |
| Abbott Laboratories | $47.70 | 2024 | Aveir |
| Abiomed | $44.16 | 2022-2024 | Impella |
| Pfizer INC. | $40.79 | 2023 | |
| Atricure, INC. | $35.07 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $35.03 | 2024 | Eliquis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $24.42 | 2025 | Artix Mt |
| Ge Healthcare | $19.47 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.58 | 2019 | |
| Angiodynamics, INC. | $11.45 | 2021 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Turk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.